Literature DB >> 2514819

Anticardiolipin antibody.

G R Hughes1, M A Khamashta.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2514819      PMCID： PMC1838319          DOI： 10.1136/bmj.299.6713.1414

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.

Authors:  M A Khamashta; E N Harris; A E Gharavi; G Derue; A Gil; J J Vázquez; G R Hughes
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

2.  The Prosser-White oration 1983. Connective tissue disease and the skin.

Authors:  G R Hughes
Journal:  Clin Exp Dermatol       Date:  1984-11       Impact factor: 3.470

3.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

4.  The anticardiolipin syndrome.

Authors:  G R Hughes
Journal:  Clin Exp Rheumatol       Date:  1985 Oct-Dec       Impact factor: 4.473

5.  Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.

Authors:  R A Asherson; D Mercey; G Phillips; N Sheehan; A E Gharavi; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103

6.  Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion.

Authors:  A M Unander; R Norberg; L Hahn; L Arfors
Journal:  Am J Obstet Gynecol       Date:  1987-01       Impact factor: 8.661

7.  Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody.

Authors:  E N Harris; R A Asherson; A E Gharavi; S H Morgan; G Derue; G R Hughes
Journal:  Br J Haematol       Date:  1985-02       Impact factor: 6.998

Review 8.  Antiphospholipid antibodies--autoantibodies with a difference.

Authors:  E N Harris; R A Asherson; G R Hughes
Journal:  Annu Rev Med       Date:  1988       Impact factor: 13.739

9.  Cerebral infarction in systemic lupus: association with anticardiolipin antibodies.

Authors:  E N Harris; A E Gharavi; R A Asherson; M L Boey; G R Hughes
Journal:  Clin Exp Rheumatol       Date:  1984 Jan-Mar       Impact factor: 4.473

10.  Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.

Authors:  R A Asherson; M A Khamashta; A Gil; J J Vazquez; O Chan; E Baguley; G R Hughes
Journal:  Am J Med       Date:  1989-04       Impact factor: 4.965
View more
  5 in total

Review 1.  'Overlap' syndromes.

Authors:  R Cervera; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

2.  Anticardiolipin antibody.

Authors:  A W Joss; M M Steven
Journal:  BMJ       Date:  1990-02-10

3.  Anticardiolipin antibodies and occlusive vascular disease of the eye: prospective study.

Authors:  C D Kalogeropoulos; P Spyrou; M I Stefaniotou; E E Tsironi; A A Drosos; K G Psilas
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

4.  Lack of correlation between anticardiolipin antibodies and peripheral autonomic nerve involvement in systemic lupus erythematosus.

Authors:  M Magarò; L Mirone; L Altomonte; A Zoli; S Angelosante
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

Review 5.  Immune Components of Liver Damage Associated with Connective Tissue Diseases.

Authors:  Aziz A Chentoufi; Youri A Serov; Mansour Alazmi; Kamaldeen Baba
Journal:  J Clin Transl Hepatol       Date:  2014-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.